Medicine and Dentistry
Gut
100%
L-Type Calcium Channel
66%
5 Hydroxyindole
66%
Catestatin
66%
Gut Microbiota
57%
Intestine Motility
46%
Analeptic
40%
Metabolite
33%
Adoptive Transfer
33%
Antiinfective Agent
33%
Probiotic Agent
33%
Ileostoma
33%
Voltage Gated Calcium Channel
26%
Disease
25%
Antibiotic Resistance
25%
Polypeptide Antibiotic Agent
22%
Muscle Contractility
18%
Fecal Microbiota Transplantation
16%
Intestinal Epithelium
16%
Targeted Therapy
16%
Chromogranin A
13%
Constipation
13%
Butyric Acid
13%
Smooth Muscle Cell
11%
Tight Junction
11%
5-Hydroxytryptophan
9%
Ethanolamine Phosphotransferase
8%
Inflammatory Bowel Disease
8%
Patient with Crohn's Disease
8%
Ulcerative Colitis
8%
Short Chain Fatty Acid
8%
Escherichia coli
8%
Immunocompetent Cell
8%
Proteinase
8%
Acetic Acid
8%
Mucosa
8%
Ex Vivo
6%
RNA 16S
6%
Gastrointestinal Motility Disorder
6%
Enhancer Region
6%
Enteritis
5%
Inflammatory Disorder
5%
Colon
5%
Fatty Acid Metabolism
5%
Homeostasis
5%
Phylogeny
5%
Fibrosis
5%
Water-Electrolyte Imbalance
5%
Transmission Electron Microscopy
5%
Intestine Mucosa
5%
Immunology and Microbiology
Microflora
83%
Intestine Flora
51%
Knockout Mouse
50%
Wild Type Mouse
41%
Mouse
33%
Wild Type
33%
Probiotic
33%
Ileostoma
33%
Antimicrobial Resistance
25%
Antimicrobial Peptides
22%
Feces microflora
16%
Microorganism
16%
Tight Junction
11%
Crohn's Disease
8%
Metagenomics
8%
Immunocompetent Cell
8%
Escherichia coli
8%
Ulcerative Colitis
8%
Inflammatory Bowel Disease
8%
Mucosa
8%
Enteroendocrine Cell
5%
Fatty Acid Metabolism
5%
Colon
5%
Enteritis
5%
Phylogeny
5%
Homeostasis
5%
RNA Sequence
5%
Transmission Electron Microscopy
5%
Intestine Mucosa
5%
Pharmacology, Toxicology and Pharmaceutical Science
Microflora
66%
Intestine Flora
56%
Binding Potential
33%
5 Hydroxyindole
33%
Calcium Channel L Type
33%
Epileptic Absence
33%
Methylphenidate
33%
Probiotic Agent
33%
Voltage Gated Calcium Channel
26%
Bioavailability
14%
Constipation
13%
Disease
11%
Attention Deficit Disorder
9%
Drug Development
6%
RNA 16S
6%
Gastrointestinal Motility Disorder
6%